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Available online ▪ ▪ ▪AbstractPurpose: To provide efficacy and safety of Trabectome combined with phacoemulsification in primary open-angle glaucoma.
Methods: In this interventional case series, 30 consecutive eyes that have had combined phacoemulsification with Trabectome were included.
The main outcome measures were change in intraocular pressure (IOP), glaucoma medication use, and the rate of complications.
Results: Mean IOP was 18.25 ± 3.28 mmHg preoperatively which decreased to 13.50 ± 2.53 mmHg at 1 year. (P < 0.05). There was a cor-
responding drop in glaucoma medications from 2.52 ± 0.60 at baseline to 1.40 ± 0.53 at 12 months (P < 0.01). The preoperative BCVA (Log
Mar) was improved from 0.68 ± 0.26 pre-operatively to 0.26 ± 0.19, 0.18 ± 0.13, 0.17 ± 0.13, 0.11 ± 0.12, at 5 days and 2, 6, and 12 months,
respectively (P < 0.01). The only frequent complication was transient blood reflux resolving spontaneously within a few days. No vision-
threatening complication occurred.
Conclusion: Combined phacoemulsification and Trabectome significantly lowered IOP and medication use, with early visual rehabilitation in
the majority of patients.
Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Glaucoma is the second most common cause of irreversible
blindness worldwide.1 Many patients with glaucoma have
concurrent cataracts. Some studies suggest that glaucoma it-
self is a risk factor for cataract development.2e4 The benefits
of combined cataract and glaucoma surgeries include possible
elimination or at least reduction of glaucoma medications in
glaucoma patients who desire cataract surgery, but who are on
multiple glaucoma medications.5,6Financial disclosure: No financial support was received for this
submission.
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is considered the “treatment of choice” in patients with open-
angle glaucoma and cataract; however, it is associated with
postoperative complications such as hypotony, choroidal ef-
fusions, suprachoroidal hemorrhages, and endophthalmitis.7,8
Phacotrabeculectomy patients need intensive postoperative
management even without complications.9
The combination of phacoemulsification with an estab-
lished contemporary surgical technique such as Trabectome
(NeoMedix Corp., Tustin, CA) or canaloplasty may result in a
lower rate of complications.10e12 These procedures, in
contrast to trabeculectomy and aqueous tube shunt, rely on the
augmentation of the trabecular outflow pathway without the
need for external drainage of aqueous.13 Therefore, many
complications associated with external filtering procedures are
reduced or eliminated. Combined phaco-Trabectome has the
advantage of preserving conjunctiva by performing an ab-
internal trabeculotomy using electro-ablation of thection and trabeculotomy by the internal approach for coexisting cataract and
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aspiration of tissue debris.12
The purpose of this study is to evaluate results of combined
phaco and Trabectome on intraocular pressure of patients with
primary open-angle glaucoma and cataract.
Methods
This studywas an interventional case series of 28 patients (30
eyes) with uncontrolled open-angle glaucoma and cataract who
had combined phacoemulsification and trabeculotomy by the
internal approach at the Department of Ophthalmology at Iran
University of Medical Sciences. Patients were in the planned
phacoemulsification and trabeculotomy ab-interno group if they
had cataract and mild to moderate primary open-angle glau-
coma with uncontrolled IOP more than 21 mmHg while
receiving maximum tolerable anti-glaucomatous therapy or
controlled glaucoma with IOP less than 21 mmHg and cataract
and desired to decrease the number of medications.
The target IOP was determined by the treating glaucoma
specialist during follow-up according to standardized criteria
such as optic nerve cupping and retinal nerve fiber layer loss,
visual field loss, and clinical course. Patients with a history of
previous ocular surgery or corneal opacity that impaired angle
visualization were excluded. Possible alternatives, beneficial
effects, and potential complications of the surgical procedure
were explained in detail to all patients. Written informed
consent was obtained from all participants. Study was in
adherence to the tenets of the Declaration of Helsinki. Before
surgical intervention, all patients had baseline examinations
including measurements of best corrected visual acuity, visual
field examination (30e2, Humphrey Field Analyzer, model
750, Zeiss), biomicroscopy, gonioscopy, Goldmann applana-
tion tonometry, auto kerato refractometry, and corneal topog-
raphy (Topcon KR-8100P Auto kerato refractometer, Topcon).
Two experienced surgeons performed all operations. IOP was
compared to a group of age-matched phaco patients after two
months. We did not have a parallel phaco group, but we used
the information of 44 age-matched phaco groups by the same
surgeons for a comparison of IOP change. In this group, pa-
tients with glaucoma or ocular hypertension were excluded.Surgical techniqueIn all cases, the ab-interno approach of the Trabectome
(NeoMedix Corp., Tustin, CA) was performed first, followed
by cataract extraction. Standard dilating drops comprising
phenylephrine hydrochloride (Neo-Synephrine 1%) and tro-
picamide (Mydriacyl 0.5%) were instilled 30 min before the
operation. Under topical anesthesia, after the area was prepped
and draped, a 1.6 or 1.7 mm keratome was used to make a
near-limbal, temporal clear corneal incision. Preservative-free
lidocaine 2% was injected into the anterior chamber. An
ophthalmic dispersive viscosurgical device (OVD) such as
hydroxypropyl methylcellulose (Ocucoat) was injected to
form the anterior chamber. The head and microscope were
tilted to give an optimal gonioscopic view of the angle. ThePlease cite this article in press as: Hashemian SJ, et al., Combined cataract extra
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goniosurgical lens (a modified Swann-Jacobs lens) was placed
on the cornea to verify the angle landmarks. The Trabectome
handpiece was inserted and advanced nasally across the
anterior chamber with the infusion on. The pointed tip of the
footplate was inserted through the trabecular meshwork into
Schlemm's canal, and a footswitch activated the aspiration and
bipolar electrodes. Using an initial power setting of
0.7e0.8 W, the surgeon slowly advanced the instrument along
the meshwork first in a counterclockwise, then in a clockwise,
direction using the limbal corneal incision as a fulcrum,
ablating and removing a strip of trabecular meshwork un-
roofing the canal of Schlemm. The power was titrated up or
down depending on the desire to ablate a wider strip of
trabecular meshwork or to minimize charring of tissue,
respectively. Verification of the cleft was performed, as the
handpiece was removed, and the angle was viewed for evi-
dence of blood reflux from the newly exposed collector
channels. After filling the anterior chamber with an OVD,
phacoemulsification and IOL implantation were then per-
formed using the surgeon's preferred technique. At the
conclusion of the procedure, depending on pupil size, for
pupils more than 6 mm, acetylcholine chloride (Miochol) was
instilled for prevention of peripheral anterior synechia. The
amount of blood in the anterior chamber was assessed. If
active bleeding was present, an air-bubble was injected into
the anterior chamber. The corneal incision was then hydrated
and checked for leakage.
Postoperative care varied according to clinical presentation
but routinely included topical steroids (Fluorometholone) 8
times daily tapered over 6 weeks and topical antibiotics 4
times daily for 5 days.
Goldmann applanation IOPs and Snellen visual acuities
were measured before and after surgery at each visit. Intra-
operative and postoperative adverse events were tabulated, and
numbers of preoperative and postoperative adjunctive medi-
cations were compared. To provide the raw data for analysis,
autokeratometry and computerized corneal videokeratoscopy
with the Topcon KR-8100P auto kerato refractometer were
performed preoperatively and 5 days, and 2 and 6 months
postoperatively. Autokeratometry results and simulated K-
values of corneal topography were used to analyze surgically
induced keratometric and topographic astigmatism,
respectively.Statistical analysisSuccess was defined as final IOP 21 mmHg and one of
the following: 20% reduction of IOP or a reduction of 1
glaucoma medications with final IOP  baseline IOP if
baseline IOP 21 mmHg. Failure was defined as a less than
20% decrease in IOP from baseline, no decrease in medica-
tions or additional need to medications or glaucoma surgery.
For statistical analysis, analysis of variance (ANOVA) was
used to compare changes in IOP and medications across
different baseline IOP subgroups. Paired sample t-test was
performed on the pre- and post-operative data.ction and trabeculotomy by the internal approach for coexisting cataract and
/10.1016/j.joco.2016.09.003
Table 3
Number of glaucoma medications preoperatively and postoperatively.




Preoperative 2.48 ± 0.58 0 3 NA 27
5 day 1.00 ± 0.00 1 1 56.41 26
2 month 1.10 ± 0.55 0 2 52.47 27
6 month 0.87 ± 0.43 0 2 61.73 27
12 month 1.00 ± 0.62 0 2 57.02 19
18 month 1.00 ± 0.58 0 2 55.56 12
24 month 1.00 ± 0.00 1 1 55.56 6
3S.J. Hashemian et al. / Journal of Current Ophthalmology xx (2016) 1e6
+ MODELResults
Table 1 shows phaco-Trabectome patient demographics.
The mean preoperative IOP was 18.25 ± 3.28 mmHg with a
mean of 2.52 ± 0.60 glaucoma medications (Tables 2 and 3).
The range of postoperative IOP and number of medications at
each time point are shown in Tables 2 and 3 and Fig. 1. The
data was available for all patients in month 6, however, 26% of
patients were missed from the follow-up at one year. Success
(i.e. 20% or greater drop in IOP or decrease in glaucoma
medications without need for additional medications or glau-
coma procedures, including laser trabeculoplasty) was 46.7%
at 6 months (n ¼ 30) and 59.1% at 12 months (n ¼ 22). The
only significant intraoperative complication was hyphema that
forms from blood reflux into Schlemm's from the aqueous
collector channels which cleared within a few days after sur-
gery. In the postoperative period, hyphema was the most
frequent complication which was observed in three patients
(10%). We had one case with an IOP spike of 3.3% which was
controlled by medications, and one case of corneal edema
(3.3%) which resolved spontaneously. There were noTable 1
Patient demographics.
Parameter Value
Patients (No. of patients/No. of eyes) 28/30
Age





Cup-to-disc ratio, n (%)
< 0.7 17 (56.7%)
0.7e0.8 12 (40.0%)
> 0.8 1 (3.3%)





Visual field loss, n (%)
Mild (MD 0 to 6.0 dB) 2 (6.7%)
Moderate (MD 6.0 to 12.0) 26 (86.7%)
Severe (MD > 12.0) 2 (6.7%)
No. ¼ Number of eyes; MD ¼ mean deviation;
Table 2











Preoperative 12 32 18.57 ± 4.73 NA 30
1 day 8 20 14.21 ± 3.41 20.21 29
5th day 9 28 13.59 ± 3.53 22.61 29
2th month 10 20 14.10 ± 2.47 20.26 30
6th month 10 20 13.90 ± 2.50 21.35 30
12th month 9 19 13.86 ± 2.66 24.77 22
18th month 12 20 14.31 ± 2.18 19.48 13
24th month 12 15 13.33 ± 1.51 28 6
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orrhage, aqueous misdirection, infection, bleb formation or
wound leaks or cystoid macular edema.
Table 4 shows an analysis of IOP and glaucoma medication
reduction stratified by baseline IOP level. Patients were
separated into low pressure (<21 mmHg) group and high
pressure (21 mmHg) group based on baseline IOP. The high
pressure group had a statistically significant greater decrease
in IOP level. No significant difference in medications drop was
observed between the two groups (Fig. 2 and Table 4).
The visual acuity (LogMar values) level from the preop-
erative period was statistically significantly different
throughout follow-up. The preoperative BCVA (LogMar) was
0.68 ± 0.26 and was improved post operatively to 0.26 ± 0.19,
0.18 ± 0.13, 0.17 ± 0.13, 0.11 ± 0.12, 0.13 ± 0.081 at 5 days
and 2, 6, 12, and 24 months, respectively (P < 0.01).
The mean keratometry decreased slightly 2 months post-
operatively and remained stable to 6 months post operation.
Changes in mean keratometry between preoperative and
postoperative examinations were not statistically significant
(P ¼ 0.13). The mean surgical induced astigmatism (absolute
keratometric changes) was 0.38 ± 0.28D.
As mentioned before, 44 patients with only phaco surgery
served as the control group for IOP comparison after 2 months.
In the phaco group, themean agewas 63.36± 11.48with amean
IOP of 14.73 ± 2.49 mmHg before surgery. Mean IOP was
significantly different at baseline between these two groups
because all cases in the phaco-Trabectome group had uncon-
trolled glaucoma (P < 0.05). IOP was reduced to
12.3 ± 2.5 mmHg two months after surgery, but this difference
was not significant in contrast to the phaco-Trabectome group
(Fig. 3). The decrease in IOP after 2 months in the phaco-
Trabectome group was 4.4 ± 5.1 mmHg and 2.45 ±
2.19 mmHg in the phaco-group (P < 0.04).
Discussion
Glaucoma is the second cause of irreversible blindness in
the world.1 Glaucoma management has evolved during the
past decade by the introduction of new methods of surgical
techniques and medications. Glaucoma and cataract are
common in older patients.2 Although phacoemulsification in
combination with trabeculectomy is effective for controlling
pressure, complications such as hypotony, choroidal effusion
and hemorrhage, leaking blebs, and endophthalmitis tend toction and trabeculotomy by the internal approach for coexisting cataract and
/10.1016/j.joco.2016.09.003
Fig. 1. Decreasing trend of intraocular pressure during follow-up at 8 time points after surgery (from left, first day, 5th day, 2, 5, 6, 12, 18 and 24 months).
Fig. 2. Dot plot with fitted lines for all of the intraocular pressure (IOP) reduction
months).
Table 4
Reduction in intraocular pressure (IOP) stratified by baseline IOP.







First day 15.04 40.03 0.02
Day 5 15.88 48.39 <0.01
Month 2 14.46 43.43 <0.01
Month 5 15.88 48.39 <0.01
Month 6 15.1 46.38 <0.01
Month 12 16.88 51.6 <0.01
Month 18 11.32 46.71 <0.01
Month 24 16.5 51 0.04
4 S.J. Hashemian et al. / Journal of Current Ophthalmology xx (2016) 1e6
+ MODEL
Please cite this article in press as: Hashemian SJ, et al., Combined cataract extra
open-angle glaucoma, Journal of Current Ophthalmology (2016), http://dx.doi.orgoccur.7,8 Cataract surgery alone in glaucoma patients lowers
IOP by 2e4 mmHg for a couple years.14e16 Even though
phaco can reduce IOP, there is strong evidence for better long-
term control of IOP in glaucoma patients with combined
glaucoma surgery (trabeculectomy) and cataract extraction
compared with cataract surgery alone.17,18
A combination of phaco with new surgical techniques such
as Trabectome, endoscopic cyclophotocoagulation (ECP),
Solx Gold shunt, canaloplasty or express shunt result in a
lower rate of complications.9e12 Given that Trabectome does
not require the use of antifibrotic agents, risks associated with
the use of mitomycin-C and 5-fluorouracil are therefore
eliminated. Because the ab-interno approach of Trabectome
completely spares the conjunctiva, any future standard filtering
procedures remain available options if needed.19(DIOP) at 8 time points after surgery (first day, 5th day, 2, 5, 6, 12, 18 and 24
ction and trabeculotomy by the internal approach for coexisting cataract and
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Fig. 3. Comparison of intraocular pressure reduction between the two groups at 2 months after surgery.
5S.J. Hashemian et al. / Journal of Current Ophthalmology xx (2016) 1e6
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in IOP after the operation. The mean preoperative IOP was
reduced from 18.2 ± 3.2 mmHg to 14.5 ± 2.3 mmHg at 6
months, and 13.5 ± 2.5 mmHg at 12 months.
Minckler et al reported that for 45 patients undergoing
combined Trabectome and cataract extraction, the baseline
IOP of 20.0 ± 6.2 mmHg was decreased to 15.9 ± 3.3 mmHg
(18%), and medications decreased from 2.63 ± 1.12 to
1.50 ± 1.36 at 12 months.20 In our study, 46.7% showed an
reduction in the number of medications from 3 to 1 after 12
months of follow-up. In a study of 538 patients that had
Trabectome surgery alone and 290 patients that had phaco
combined, Mosaed et al reported a 31% IOP reduction and a
28% drop in medication usage in the Trabectome only group
at 1 year of follow-up. In the combined group, a 18% IOP
reduction and 33% drop in medication were reported.21 In a
prospective case series comprised of 304 eyes with open-angle
glaucoma and cataract, Francis et al reported a mean preop-
erative IOP 20.0 ± 6.3 mmHg preoperatively that decreased to
15.5 ± 2.9 mmHg at one year after combined Trabectome and
phacoemulsification surgery. The glaucoma medications
dropped from mean 2.56 ± 1.13 to a mean 1.44 ± 1.29 at one
year.12 In our study, glaucoma medication decreased from
2.48 ± 0.58 before surgery to 0.95 ± 0.38 at 6 months. At 12
months, the number of medications was 1.14 ± 0.53. In the
phaco group, IOP decreased from baseline, but the change was
not significant compared to the phaco-Trabectome group.
The most common complication reported in the study of
Francis et al was blood reflux, which was observed in 78.4%
of patients.12 Blood reflux was observed in 90.0% our patients.
Meanwhile, we observed significant improvement in VA
and a small amount of induced astigmatism after surgery.
Trabeculectomy produces, during the early post-operative
period, a reduction in the vertical corneal radius and results
in with-the-rule (WTR) a change in corneal astigmatism.22,23
We observed less astigmatism in those patients who had
combined phacoemulsification and ab-interno TrabectomePlease cite this article in press as: Hashemian SJ, et al., Combined cataract extra
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Cairns-type technique.24,25
When considering the cost associated with glaucoma
medications and challenges of medical compliance, it is
certainly noteworthy that combined surgery reduced medica-
tion use by about 57% in 12 months of follow-up in our study.
Complications observed after surgery such as hyphema were
transient, and complications such as hypotony and choroidal
effusion were not observed in our study.
It seems that the combination of phaco with ab-interno
Trabectome may be a good option for patients with mild to
moderate glaucoma and cataract. It not only decreases IOP but
also dependence on glaucoma medications.
The study had several limitations including small sample
size, absence of a matched control group and short-term
follow-up. Unfortunately, the data of about 26% of our pa-
tients was not available at one year of follow-up. Also, we did
not have information of the Phaco group in the long term as a
parallel group. Considering that the primary goal of any
glaucoma surgery is the reduction of IOP with the lowest
requirement for adjunctive glaucoma medications while
providing minimal risk of complications, our results showed
that combining phacoemulsification and Trabectome lowered
IOP and medication use, with early visual rehabilitation and
stable refractive outcomes in the majority of our patients.References
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